Reducing and managing chronic obstructive pulmonary disease exacerbations with tiotropium  + olodaterol.

Conclusions: The early stages of COPD may represent a "window of therapeutic opportunity", when initiation of tiotropium and olodaterol dual bronchodilator therapy may improve lung function and quality of life and reduce exacerbations in patients with COPD. PMID: 33095662 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research